Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Director acquired 9,581 shares (grant or award)
  6. 4 Grant or award Director acquired 7,841 shares (grant or award)
  7. 4 Shares withheld for taxes President & CEO gave up 22,217 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Legal Officer gave up 5,049 shares (to pay taxes)
  9. 4 Planned sale Chief Business Officer sold 1,159 shares at $3.15 ($3,651)
  10. 4 Shares withheld for taxes Chief Accounting Officer gave up 1,586 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief People Officer gave up 4,103 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Financial Officer gave up 6,422 shares (to pay taxes)
  13. 4 Grant or award Chief Scientific Officer acquired 28,200 shares (grant or award)
  14. 4 Shares withheld for taxes Chief Medical Officer gave up 5,145 shares (to pay taxes)
  15. 4 Grant or award Director acquired 3,757 shares (grant or award)
  16. 4 Grant or award Director acquired 3,074 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Shares withheld for taxes Chief Business Officer gave up 1,102 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Financial Officer gave up 1,102 shares (to pay taxes)

Page 3 of 15 · 296 filings